BioAtlantis Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.02M

  • Investors
  • 1

BioAtlantis General Information

Description

Developer of natural bio-actives designed for the use of in-feed growth-promoting antibiotics in the agricultural sector. The company's natural bio-actives offer nutraceutical ingredients that include plant biostimulants and animal prebiotics made from molecules derived from seaweeds which protect crops from stress in soils with low organic matter content or pathogenic infestation and promote plant health and growth, enabling the agriculture sector to alleviate problems caused by biotic and abiotic stresses, extreme weather and climatic conditions.

Contact Information

Website
www.bioatlantis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Agricultural Chemicals
Other Industries
Cultivation
Primary Office
  • Clash Industrial Estate
  • Co. Kerry
  • Tralee V92 RWV5
  • Ireland
+353 (066) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAtlantis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Mar-2010 $1.02M 00.000 Completed Generating Revenue
To view BioAtlantis’s complete valuation and funding history, request access »

BioAtlantis Patents

  • 28

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

BioAtlantis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3295795-A1 Use of a non-nematicidal composition Pending 20-Mar-2013 000000000 00
EP-2975937-A1 A non-nematicidal composition and use thereof Inactive 20-Mar-2013 000000000
US-20160029627-A1 A non-nematicidal composition and use thereof Active 20-Mar-2013 000000000
US-10433549-B2 Non-nematicidal composition and use thereof Active 20-Mar-2013 000000000
US-11582969-B2 Non-nematicidal composition and use thereof Active 20-Mar-2013 A01N43/16 00
To view BioAtlantis’s complete patent history, request access »

BioAtlantis Executive Team (7)

Name Title Board Seat Contact Info
John O'Sullivan Chief Executive Officer
John O'Brien Financial Controller
T.J. Greaney Operations Manager
Begona Morales Senior International Sales & Business Development Manager
You’re viewing 4 of 7 executive team members. Get the full list »

BioAtlantis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioAtlantis Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kernel Management Partners Venture Capital Minority 000 0000 000000 0
To view BioAtlantis’s complete investors history, request access »

Ready to get started?

Request a free trial